Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome
Jeffrey L. Neul, Alan K. Percy, Tim A. Benke, et al.
Pediatric Neurology (2023) Vol. 152, pp. 63-72
Open Access | Times Cited: 14

Showing 14 citing articles:

Exposure–Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome
Mona Darwish, Julie Passarell, James M. Youakim, et al.
Advances in Therapy (2024) Vol. 41, Iss. 4, pp. 1462-1480
Open Access | Times Cited: 5
Rett Syndrome: The Emerging Landscape of Treatment Strategies
Alan K. Percy, Amitha Ananth, Jeffrey L. Neul
CNS Drugs (2024)
Open Access | Times Cited: 4
Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2–4 years with Rett syndrome
Alan K. Percy, Robin Ryther, Eric D. Marsh, et al.
Med (2025), pp. 100608-100608
Open Access
A Blueprint for Translational Precision Medicine in Autism Spectrum Disorder and Related Neurogenetic Syndromes
Robyn P. Thom, Tracy L. Warren, Suha Khan, et al.
Journal of Child and Adolescent Psychopharmacology (2025)
Closed Access
Rett syndrome: The Natural History Study journey
Alan K. Percy, Tim A. Benke, Eric D. Marsh, et al.
Annals of the Child Neurology Society (2024) Vol. 2, Iss. 3, pp. 189-205
Open Access | Times Cited: 2
Is trofinetide a future treatment for Rett syndrome? A comprehensive systematic review and meta-analysis of randomized controlled trials
Hazem Mohammed, Zeyad Bady, Mohamed E. Haseeb, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA
Jenny Downs, Dominique C. Pichard, Walter E. Kaufmann, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Pavalan Selvam, Carlos F. Mares Beltrán, Kuntal Sen, et al.
Genetics in Medicine Open (2024) Vol. 2, pp. 101856-101856
Open Access
Improvement in symptoms of Rett syndrome with trofinetide beyond clinical trial efficacy assessments: case reports
Robin C. Ryther, Christine Palladino, Sanjeev V. Kothare
Future Rare Diseases (2024) Vol. 4, Iss. 1
Open Access
Rett syndrome: A coming of age
Alan K. Percy
Translational Science of Rare Diseases (2024), pp. 1-13
Open Access
Genetic Testing History in Adults with Autism Spectrum Disorder
Susanna B. Mierau, Robyn P. Thom, Caitlin Ravichandran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Assessing Communication Impairments in a Rare Neurodevelopmental Disorder
Anne T. Berg, Amanda N. Nili, Lindsey Evans, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access
A New Hope in The Treatment of Rett Syndrome: Trofinetide
Doğancan Sönmez
Phoenix Medical Journal (2024)
Open Access
Evaluation of social preference, anxiety, cortisol, and chemically-induced hyperlocomotion in mecp2 null-mutant zebrafish
Soaleha Shams, Pierre Cronell, Jenny Landin, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top